Gastro Medical News about GOO

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A systematic review of methods to palliate malignant gastric outlet obstruction
Surgical Endoscopy, 07/01/09

Ly J et al. - This review demonstrates improved clinical outcomes with ES over OGJ for patients with malignant GOO. However, there is insufficient data to adequately compare ES with LGJ, which is the current standard for operative management. As these conclusions are based on observational studies only, future large well-designed randomised controlled trials would be required to ensure the estimates of the relative efficacy of these interventions are valid.

Exclusive Author Commentary
John A. Windsor, 07/01/09

The benefits of ES in our own practice has been a revelation and is now our preferred approach to the palliative management of pyloric and duodenal malignant obstruction. And this is despite being enitrely comfortable with the technique of stapled laparoscopic gastro-jejunostomy. With the latter we take down the momentum and perform a antecolic, distal and posterior gastro-jejunostomy, which is the preferred approach. While strictly speaking, in the absence of level 1 evidence there is still equipoise, in reality and as a result of our positive experience with ES, it would be difficult for us to randomize a patient to laparoscopic gastro-jejunostomy arm.

<< Previous
Is a bougie required for the performance of the fundal wrap...

Next >>
Antiviral therapy in compensated and decompensated cirrhotic...